Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Pharmaceutical Manufacturing
PT. Anvita Pharma Indonesia is a Pharmaceutical Manufacturing brand in Karawang. Ownership is privately held; it publishes at anvitapharma.com. It holds one address on record, all in Indonesia. The record counts 94 people. It is listed alongside seven similar brands, mostly in Pharmaceutical Manufacturing.
PT Anvita Pharma Indonesia is a research driven pharmaceutical company that aims to be at the forefront as a developer and producer of high quality active pharmaceutical ingredients for the needs of the Indonesian pharmaceutical industry and for export to ASEAN markets. Anvita Pharma has successfully developed technologies that reduce the risks, timelines and costs in drug development for life-saving drugs. These technologies are incorporated into our state-of-art API manufacturing plant, built on 25,000 sqm of land within KNIC, a world-class integrated industrial estate close to Jakarta in Indonesia.
| Countries | 1 |
|---|---|
| Primary country | ID |
All codes: ID
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
The record holds 94 counted staff profiles at January 2026, inside the self-reported 51–200 band.
One address on record, Indonesia only. Primary: Karawang New Industry City, Block Be No.8, Karawang.
None linked to this brand.
Seven peer profiles on record: PT Etana Biotechnologies Indonesia and PT Kalbe Farma, Tbk.